- Skakkebaek N.E.
- Rajpert-De Meyts E.
- Buck Louis G.M.
- Toppari J.
- Andersson A.M.
- Eisenberg M.L.
- Jensen T.K.
- Jorgensen N.
- Swan S.H.
- Sapra K.J.
- Ziebe S.
- Priskorn L.
- Juul A.
- De Jonge C.
- Barratt C.L.R.
Ravitsky V. and Kimmins S. The Forgotten Men: Rising rates of male infertility urgently require new approaches for its prevention, diagnosis and treatment. In Press Biology of Reproduction ioz161,https://doi.org/10.1093/biolre/ioz161
- Barratt C.L.R.
- Björndahl L.
- De Jonge C.J.
- Lamb D.J.
- Osorio Martini F.
- McLachlan R.
- Oates R.D.
- van der Poel S.
- St John B.
- Sigman M.
- Sokol R.
- Tournaye H.
- De Jonge C.
- Barratt C.L.R.
- 1Improving our basic understanding of the underlying biology is fundamental. The WHO ESG identified a key priority as ‘a better understanding of the cellular, molecular biochemical and genetic control mechanism(s) involved in the production of a human spermatozoon’. This knowledge is critical in order to formulate appropriate diagnostic assays with good predictive accuracy, develop effective therapy for the male and to understand how external factors, such as the environment, negatively or positively influence these processes.
- 2Another roadmap component comes from growing evidence that the environment influences male reproductive function. The concept of the ‘testicular dysgenesis syndrome’ was developed after the discovery that important clinical pathologies in male reproductive function start in utero and can lead to significant health consequences for the man (Skakkebaek et al., 2001;Kilcoyne and Mitchell, 2019). It is vitally important to understand and characterize the relationship of in-utero exposure and lifelong male reproductive pathology. Equally important and related, it is essential to examine the long-term health outcomes of the children born with or without ART from men with compromised fertility whatever the nature of the compromising agent(s) (genetic, environmental, occupational or iatrogenic).
- 3A comprehensive male contraceptive portfolio is required. Modern reproductive science has not led to the development of any new methods for men to control their fertility. A ‘male pill’ remains strikingly absent from current contraceptive options despite evidence that women as well as men would welcome it (Glasier et al., 2000). Encouragingly, there are a range of innovative hormonal and non-hormonal approaches currently in development, a number of which are funded by the United States National Institute for Child Health and Human Development (Reynolds-Wright and Anderson, 2019). In stark contrast is the almost complete absence of pharmaceutical industry involvement in male contraceptive development.
- 4Remarkably there is no quantitative and detailed assessment of the economic impact of male reproductive health (Barratt et al., 2018). Compelling evidence has been presented in almost all other disciplines simply because an accurate economic assessment is fundamental to (i) underpin scientific arguments and funding strategies, and (ii) inform and modify future policy. A good example is that of weather forecasting. The World Bank report on funding of weather forecasting suggested that meeting a worldwide investment need of US$1.5-2.0 billion and ongoing annual costs of ~US$500 million could save 23,000 lives per year and would garner up to US$30 billion per year in global economic benefits (Alley et al., 2019). These are powerful, hard-hitting analytical statements that undoubtedly focus the minds of policy makers. There is no such equivalent data for male reproductive health.
- 5The economic impact of male reproductive health is intimately connected to its social impact. As mentioned earlier, in general, men ’live sicker and die younger‘ than women. Cardiovascular disease and metabolic disorders predominate in men relative to women. Explanations include that men generally have unhealthy lifestyle factors and are less motivated to seek healthcare advice and treatment. Social norms, and a man‘s own sense of masculinity, influence male participation in healthcare. Social norms can play a positive role in men seeking healthcare if, for example, a partner or family member suggests that a man has a routine physical examination and he also sees other men doing the same. If men, their partners and their families can be made more aware that routine male reproductive health assessment can provide early detection of potential chronic illness, disease and cancer, then men may feel more inclined to participate in a preventive healthcare program. To accomplish the kind of societal transformation necessary requires social media formats, educational systems and the medical community. For example, Healthy Male (http://www.healthymale.org.au) is an Australian government-funded program that provides accurate information and resources to raise awareness about male reproductive health and associated chronic disease.
- De Jonge C.
- Barratt C.L.R.
References
- Not every sperm is sacred; a perspective on male infertility.Mol. Hum. Reprod. 2018; 24: 287-298
- Advances in weather prediction.Science. 2019; 363: 342-344
- A Dolce & Gabbana model in every ART clinic?.Mol. Hum. Reprod. 2018; 24: 431-432
- The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities.Hum. Reprod. Update. 2017; 23: 660-680
- ‘Man Up’: the importance and strategy for placing male reproductive health centre stage in the political and research agenda.Hum. Reprod. 2018; 33: 541-545
- Transgenerational Epigenetic Inheritance.Annu. Rev. Genet. 2018; 52 (23): 21-41
- The present crisis in male reproductive health: an urgent need for a political, social, and research roadmap.Andrology. 2019; https://doi.org/10.1111/andr.12673
- Semen quality, infertility and mortality in the USA.Hum. Reprod. 2014; 29: 1567-1574
- Relationship between semen production and medical comorbidity.Fertil. Steril. 2015; 103: 66-71
- Would women trust their partners to use a male pill?.Hum. Reprod. 2000; 15: 646-649
- Effect of environmental and pharmaceutical exposures on fetal testis development and function: a systematic review of human experimental data.Hum. Reprod. Update. 2019; 25: 397-421
- Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes.Nat. Commun. 2013; 4: 2889
- Semen Quality as a Predictor of Subsequent Morbidity: A Danish Cohort Study of 4,712 Men With Long-Term Follow-up.Am. J. Epidemiol. 2017; 186: 910-917
- Temporal trends in sperm count: a systematic review and meta-regression analysis.Hum. Reprod. Update. 2017; 23: 646-659
- Paternal preconception folate intake in relation to gestational age at delivery and birthweight of newborns conceived through assisted reproduction.Reprod. BioMed. 2019; (Online (this issue))
Ravitsky V. and Kimmins S. The Forgotten Men: Rising rates of male infertility urgently require new approaches for its prevention, diagnosis and treatment. In Press Biology of Reproduction ioz161,https://doi.org/10.1093/biolre/ioz161
- A call for gender-inclusive global health strategies.Am. J. Mens Health. 2017; 11: 1804-1808
- Populations, decreasing fertility, and reproductive health.Lancet. 2019; 393: 1500-1501
- Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects.Hum. Reprod. 2001; 16: 972-978
- Male Reynolds-Wright, JJ & Anderson RA Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility.Physiol. Rev. 2016; 96: 55-97
- Male contraception: where are we going and where have we been?.BMJSRH. 2019;
- Wanted: academics wise to the needs of government.Nature. 2017; 552 (2017): 7